Get started
Author

Matthew A. Cunningham

Intravitreal Steroids for Macular Edema: The Past, the Present, and the Future
2008 · Matthew A. Cunningham, Jeffrey L. Edelman, et al. · Survey of Ophthalmology · 147
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024 · David M Brown, David S Boyer, et al. · The Lancet · 135
PDF
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
2022 · Chirag D. Jhaveri, Adam R. Glassman, et al. · New England Journal of Medicine · 91
PDF
The Scope Of Three-Dimensional Digital Visualization Systems In Vitreoretinal Surgery
2019 · Joshua S Agranat, John B Miller, et al. · Clinical ophthalmology · 67
PDF
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
2023 · Raj K. Maturi, Adam R. Glassman, et al. · JAMA · 65
TSLP and Downstream Molecules in Experimental Mouse Allergic Conjunctivitis
2010 · Xiaofen Zheng, Ping Ma, et al. · Investigative Ophthalmology & Visual Science · 57
Bilateral Retinal Detachments After Intravitreal Injection of Adipose-Derived ‘Stem Cells’ in a Patient With Exudative Macular Degeneration
2017 · Steven S. Saraf, Matthew A. Cunningham, et al. · Ophthalmic surgery, lasers & imaging retina · 50
Proliferative Vitreoretinopathy May Be a Risk Factor in Combined Macular Hole Retinal Detachment Cases
2012 · Matthew A. Cunningham, Ryan M. Tarantola, et al. · Retina · 31
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema
2023 · David W. Hutton, Adam R. Glassman, et al. · JAMA Ophthalmology · 28
Management and Outcome of Microbial Anterior Scleritis
2011 · Matthew A Cunningham, Jamie K Alexander, et al. · Cornea · 28
LX211 (Voclosporin) Suppresses Experimental Uveitis and Inhibits Human T Cells
2009 · Matthew A. Cunningham, Bobbie Ann Austin, et al. · Investigative Ophthalmology & Visual Science · 28
Acanthamoeba Endophthalmitis After Recurrent Keratitis and Nodular Scleritis
2016 · Zaid Mammo, David R. P. Almeida, et al. · Retinal Cases & Brief Reports · 20
Optic neuropathy and perichiasmal tuberculomas associated with Mycobacterium tuberculosis meningitis in pregnancy
2009 · Steven Yeh, Matthew A. Cunningham, et al. · Canadian Journal of Ophthalmology · 12
Sequential, Acute Noninfectious Uveitis Associated With Separate Intravitreal Injections of Bevacizumab and Ranibizumab
2013 · Matthew A. Cunningham, Paul Tlucek, et al. · Retinal Cases & Brief Reports · 10
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
2025 · Won Ki Lee, Tien Y. Wong, et al. · JAMA Ophthalmology · 8
Small-Gauge Pars Plana Vitrectomy for Visually Significant Vitreous Floaters
2020 · Samantha Fink, Jaya B. Kumar, et al. · Journal of VitreoRetinal Diseases · 7
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathy
2024 · Quan Dong Nguyen, Justis P. Ehlers, et al. · Eye · 5
Full-Thickness Macular Hole Formation After Repair of Rhegmatogenous and Tractional Retinal Detachment
2019 · Matthew A. Cunningham, Samantha Fink, et al. · Journal of VitreoRetinal Diseases · 3
OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium
2013 · Matthew A Cunningham, Zhuqing Li, et al. · Journal of Ophthalmic Inflammation and Infection · 3
PDF
Retinal Detachment in a Patient With Leber Congenital Amaurosis
2012 · Matthew A. Cunningham, H. Culver Boldt, et al. · Retinal Cases & Brief Reports · 3
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics
2026 · Richard P. Gale, Anat Loewenstein, et al. · Ophthalmology Retina · 2
Clinical features and diagnosis of retinoblastoma
2013 · Matthew A Cunningham, H Culver Boldt · 2
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
2025 · Kiyoshi Suzuma, Toshinori Murata, et al. · Japanese Journal of Ophthalmology · 1
PDF
Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension
2026 · Justus G. Garweg, Varun Chaudhary, et al. · Ophthalmology Retina
Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial
2026 · Jean-François Korobelnik, Sergio Leal, et al. · Eye
Works count: 31
Citation count: 801
H-index: 12
I10-index: 14
Year
Topic
Type